Neurosense Therapeutics Ltd
NRSNW
Ver gráfico detalhado
0.440USD
+0.090+25.61%
Fechamento 09/19, 16:00（ET）Cotações atrasadas em 15 min
0.00Valor de mercado
--P/L TTM
Intraday
1m
30m
1h
D
W
M
D
Hoje
+25.61%
5 Dias
+4.19%
1 Mês
-36.23%
6 Meses
+112.56%
Ano até a data
0.00%
Um ano
+158.98%
Ver gráfico detalhado
Avaliação de Ações TradingKey
Não há mais dados
Notícias
Mais notícias em breve, fique ligado...
Indicadores Financeiros
EPS
Sem dados
Receita Total
Sem dados
Empresa
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Código da empresaNRSNW
EmpresaNeurosense Therapeutics Ltd
CEOMr. Alon Ben-Noon
Sitehttps://www.neurosense-tx.com/
Produtos relacionados
+0.68%
+1.38%
-2.48%
-1.57%
-0.75%
-0.09%
+1.34%
-1.77%
-0.67%
-3.03%
-0.85%
-0.87%
-0.50%
+0.44%
-0.19%
-1.18%
-2.84%
0.00%
+0.30%
-3.72%
